Neue Entwicklungen in der Therapie des fortgeschrittenen Hodgkin-LymphomsNew developments in the treatment of advanced Hodgkin’s lymphoma

被引：0

作者：

S. Kreissl

D. Eichenauer

P. Borchmann

机构：

[1] Universitätsklinik Köln,Klinik I für Innere Medizin

[2] German Hodgkin Study Group,undefined

来源：

Der Onkologe | 2014年 / 20卷 / 5期

关键词：

Hodgkin-Lymphom; BEACOPP; Gesamtüberleben; Brentuximab Vedotin; Targeted BEACOPP; Hodgkin’s lymphoma; BEACOPP; Overall survival; Brentuximab vedotin; Targeted BEACOPP;

D O I：

10.1007/s00761-013-2637-3

中图分类号：

学科分类号：

摘要：

引用

页码：457 / 463

页数：6

共 16 条

[1]

Engert undefined(2012)undefined Lancet 379 1791-undefined

[2]

Connors undefined(2011)undefined N Engl J Med 365 264-undefined

[3]

Diehl undefined(2003)undefined N Engl J Med 348 2386-undefined

[4]

Wongso undefined(2012)undefined Haematologica abs 1111 457-undefined

[5]

Behringer undefined(2013)undefined J Clin Oncol 31 231-undefined

[6]

Behringer undefined(2012)undefined Ann Oncol 23 1818-undefined

[7]

Gordon undefined(2013)undefined J Clin Oncol 31 684-undefined

[8]

Hoskin undefined(2009)undefined J Clin Oncol 27 5390-undefined

[9]

Viviani undefined(2011)undefined N Engl J Med 365 203-undefined

[10]

Mounier undefined(2013)undefined Hematol Oncol 31 96-undefined

← 1 2 →